The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.
Death receptors in chemotherapy and cancer
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Signal transduction by the JNK group of MAP kinases
Davis, R. J. (2000) · Cell · doi:10.1016/s0092-8674(00)00116-1 · Cited by 4,237
Rosenwald, A., Wright, G., Chan, W. C., Connors, J. M., Campo, E., Fisher, R. I., Gascoyne, R. D., Muller-Hermelink, H. K., Smeland, E. B., Giltnane, J. M., et al. (2002) · New England Journal of Medicine · doi:10.1056/nejmoa012914 · Cited by 3,829
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
Two CD95 (APO‐1/Fas) signaling pathways
Scaffidi, C., Fulda, S., Srinivasan, A., Friesen, C., Li, F., Tomaselli, K. J., Debatin, K., Krammer, P. H., & Peter, M. E. (1998) · The EMBO Journal · doi:10.1093/emboj/17.6.1675 · Cited by 3,000
Self-citationIdentification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900
Mammalian Caspases: Structure, Activation, Substrates, and Functions During Apoptosis
Earnshaw, W. C., Martins, L. M., & Kaufmann, S. H. (1999) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.68.1.383 · Cited by 2,760
Biochemical Pathways of Caspase Activation During Apoptosis
Budihardjo, I., Oliver, H., Lutter, M., Luo, X., & Wang, X. (1999) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.15.1.269 · Cited by 2,565
Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo.
Walczak, H., Miller, R. E., Ariail, K., Gliniak, B., Griffith, T. S., Kubin, M., Chin, W., Jones, J., Woodward, A., Le, T., et al. (1999) · Nature Medicine · doi:10.1038/5517 · Cited by 2,497
NF-κB in cancer: from innocent bystander to major culprit
Karin, M., Cao, Y., Greten, F. R., & Li, Z.-W. (2002) · Nature Reviews Cancer · doi:10.1038/nrc780 · Cited by 2,478
Safety and antitumor activity of recombinant soluble Apo2 ligand
Ashkenazi, A., Pai, R. C., Fong, S., Leung, S., Lawrence, D. A., Marsters, S. A., Blackie, C., Chang, L., McMurtrey, A. E., Hebert, A., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci6926 · Cited by 2,213
Death and anti-death: tumour resistance to apoptosis
Igney, F. H., & Krammer, P. H. (2002) · Nature Reviews Cancer · doi:10.1038/nrc776 · Cited by 2,075
Self-citationFas Ligand-Induced Apoptosis as a Mechanism of Immune Privilege
Griffith, T. S., Brunner, T., Fletcher, S. M., Green, D. R., & Ferguson, T. A. (1995) · Science · doi:10.1126/science.270.5239.1189 · Cited by 2,005
Caspase-3 Is Required for DNA Fragmentation and Morphological Changes Associated with Apoptosis
Jänicke, R. U., Sprengart, M. L., Wati, M. R., & Porter, A. G. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.16.9357 · Cited by 1,953
Johnstone (2002) · doi:10.1016/s0092-8674(02)00625-6 · Cited by 1,876
Lowe, S. W., & Lin, A. W. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.485 · Cited by 1,876
Endonuclease G is an apoptotic DNase when released from mitochondria
Li, L. Y., Luo, X., & Wang, X. (2001) · Nature · doi:10.1038/35083620 · Cited by 1,787 · cited 3×
“…is initiated by the release of apoptogenic factors such as cytochrome c, Smac/Diablo, Omi/HtrA2, endonuclease G, caspase-2 or -9 from the mitochondrial intermembrane space (Du et al., 2000; Kroemer and Reed, 2000; Suzuki et al., 2000; Li et al., 2001a, b; van Loo et al., 2002; Fulda et al., 2002).”
BackgroundThe Receptor for the Cytotoxic Ligand TRAIL
Pan, G., O'Rourke, K., Chinnaiyan, A. M., Gentz, R., Ebner, R., Ni, J., & Dixit, V. M. (1997) · Science · doi:10.1126/science.276.5309.111 · Cited by 1,767
IAP proteins: blocking the road to death's door
Salvesen, G. S., & Duckett, C. S. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm830 · Cited by 1,756 · cited 3×
“…have been shown to be highly expressed in various tumors including neuroblastoma, melanoma, breast cancer, non-small-cell lung tumors, gastrointestinal cancer and leukemia, suggesting a key role of this proteins in preventing cell death in cancer cells (Altieri, 2001; Salvesen and Duckett, 2002).”
BackgroundCD95's deadly mission in the immune system
Krammer, P. H. (2000) · Nature · doi:10.1038/35037728 · Cited by 1,717
Self-citationFour deaths and a funeral: from caspases to alternative mechanisms
Leist, M., & Jäättelä, M. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35085008 · Cited by 1,587
An Antagonist Decoy Receptor and a Death Domain-Containing Receptor for TRAIL
Pan, G., Ni, J., Wei, Y.-F., Yu, G.-L., Gentz, R., & Dixit, V. M. (1997) · Science · doi:10.1126/science.277.5327.815 · Cited by 1,496
p53 Status and the Efficacy of Cancer Therapy in Vivo
Lowe, S. W., Bodis, S., McClatchey, A., Remington, L., Ruley, H. E., Fisher, D. E., Housman, D. E., & Jacks, T. (1994) · Science · doi:10.1126/science.7973635 · Cited by 1,469
Molecular thanatopsis: a discourse on the BCL2 family and cell death
Yang, E., & Korsmeyer, S. (1996) · Blood · doi:10.1182/blood.v88.2.386.bloodjournal882386 · Cited by 1,332
Rampino, N., Yamamoto, H., Ionov, Y., Li, Y., Sawai, H., Reed, J. C., & Perucho, M. (1997) · Science · doi:10.1126/science.275.5302.967 · Cited by 1,326
Differential Requirement for Caspase 9 in Apoptotic Pathways In Vivo
Hakem, R., Hakem, A., Duncan, G. S., Henderson, J. T., Woo, M., Soengas, M. S., Elia, A., de la Pompa, J. L., Kagi, D., Khoo, W., et al. (1998) · Cell · doi:10.1016/s0092-8674(00)81477-4 · Cited by 1,292
Induction of Apoptosis by Cancer Chemotherapy
Kaufmann, S. H., & Earnshaw, W. C. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4838 · Cited by 1,266 · cited 3×
“For example, caspase activity was detected in leukemia and lymphoma cells during treatment in vivo (Kaufmann and Earnshaw, 2000; Stahnke et al., 2001, 2003; Kaufmann and Vaux, 2003).”
BackgroundMelanoma Cell Expression of Fas(Apo-1/CD95) Ligand: Implications for Tumor Immune Escape
Hahne, M., Rimoldi, D., Schröter, M., Romero, P., Schreier, M., French, L. E., Schneider, P., Bornand, T., Fontana, A., Lienard, D., et al. (1996) · Science · doi:10.1126/science.274.5291.1363 · Cited by 1,249
Varfolomeev, E. E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J. S., Mett, I. L., Rebrikov, D., Brodianski, V. M., Kemper, O. C., Kollet, O., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80609-3 · Cited by 1,234
Validating survivin as a cancer therapeutic target
Altieri, D. C. (2003) · Nature Reviews Cancer · doi:10.1038/nrc968 · Cited by 1,206
Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL
Emery, J. G., McDonnell, P., Burke, M. B., Deen, K. C., Lyn, S., Silverman, C., Dul, E., Appelbaum, E. R., Eichman, C., DiPrinzio, R., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.23.14363 · Cited by 1,184
A role for CD95 ligand in preventing graft rejection
Bellgrau, D., Gold, D., Selawry, H., Moore, J., Franzusoff, A., & Duke, R. C. (1995) · Nature · doi:10.1038/377630a0 · Cited by 1,155
Apaf1 Is Required for Mitochondrial Pathways of Apoptosis and Brain Development
Yoshida, H., Kong, Y.-Y., Yoshida, R., Elia, A. J., Hakem, A., Hakem, R., Penninger, J. M., & Mak, T. W. (1998) · Cell · doi:10.1016/s0092-8674(00)81733-x · Cited by 1,138
Suzuki, Y., Imai, Y., Nakayama, H., Takahashi, K., Takio, K., & Takahashi, R. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00341-0 · Cited by 1,116
KILLER/DR5 is a DNA damage–inducible p53–regulated death receptor gene
Wu, G. S., Burns, T. F., McDonald, E. R., Jiang, W., Meng, R., Krantz, I. D., Kao, G., Gan, D.-D., Zhou, J.-Y., Muschel, R., et al. (1997) · Nature Genetics · doi:10.1038/ng1097-141 · Cited by 1,083
An alternative, nonapoptotic form of programmed cell death
Sperandio, S., de Belle, I., & Bredesen, D. E. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.26.14376 · Cited by 1,006
Dysregulation of Apoptosis in Cancer
Reed, J. C. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.9.2941 · Cited by 987
Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5
Kischkel, F. C., Lawrence, D. A., Chuntharapai, A., Schow, P., Kim, K. J., & Ashkenazi, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80212-5 · Cited by 975
Friesen, C., Herr, I., Krammer, P. H., & Debatin, K.-M. (1996) · Nature Medicine · doi:10.1038/nm0596-574 · Cited by 974
Self-citationNagata, S. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4834 · Cited by 905
Strand, S., Hofmann, W. J., Hug, H., Müller, M., Otto, G., Strand, D., Mariani, S. M., Stremmel, W., Krammer, P. H., & Galle, P. R. (1996) · Nature Medicine · doi:10.1038/nm1296-1361 · Cited by 897
Self-citationFADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis
Yeh, W.-C., Pompa, J. L. D. L., McCurrach, M. E., Shu, H.-B., Elia, A. J., Shahinian, A., Ng, M., Wakeham, A., Khoo, W., Mitchell, K., et al. (1998) · Science · doi:10.1126/science.279.5358.1954 · Cited by 893
Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
Miyashita, T., & Reed, J. (1993) · Blood · doi:10.1182/blood.v81.1.151.151 · Cited by 882
p53 Activates the CD95 (APO-1/Fas) Gene in Response to DNA Damage by Anticancer Drugs
Müller, M., Wilder, S., Bannasch, D., Israeli, D., Lehlbach, K., Li-Weber, M., Friedman, S. L., Galle, P. R., Stremmel, W., Oren, M., et al. (1998) · The Journal of Experimental Medicine · doi:10.1084/jem.188.11.2033 · Cited by 878
Self-citationThe Fas counterattack: Fas-mediated T cell killing by colon cancer cells expressing Fas ligand.
O'Connell, J., O'Sullivan, G. C., Collins, J. K., & Shanahan, F. (1996) · The Journal of experimental medicine · doi:10.1084/jem.184.3.1075 · Cited by 878
Apo2L/TRAIL and its death and decoy receptors
LeBlanc, H. N., & Ashkenazi, A. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401187 · Cited by 854
Jo, M., Kim, T.-H., Seol, D.-W., Esplen, J. E., Dorko, K., Billiar, T. R., & Strom, S. C. (2000) · Nature Medicine · doi:10.1038/75045 · Cited by 843
Wang, L., Miura, M., Bergeron, L., Zhu, H., & Yuan, J. (1994) · Cell · doi:10.1016/s0092-8674(94)90422-7 · Cited by 836
Degli-Esposti, M. A., Dougall, W. C., Smolak, P. J., Waugh, J. Y., Smith, C. A., & Goodwin, R. G. (1997) · Immunity · doi:10.1016/s1074-7613(00)80399-4 · Cited by 821
Teitz, T., Wei, T., Valentine, M. B., Vanin, E. F., Grenet, J., Valentine, V. A., Behm, F. G., Look, A. T., Lahti, J. M., & Kidd, V. J. (2000) · Nature Medicine · doi:10.1038/75007 · Cited by 811
Cellular stress response and apoptosis in cancer therapy
Herr, I., & Debatin, K.-M. (2001) · Blood · doi:10.1182/blood.v98.9.2603 · Cited by 800
Self-citationSprick, M. R., Weigand, M. A., Rieser, E., Rauch, C. T., Juo, P., Blenis, J., Krammer, P. H., & Walczak, H. (2000) · Immunity · doi:10.1016/s1074-7613(00)80211-3 · Cited by 794
Self-citationCampos, L., Rouault, J., Sabido, O., Oriol, P., Roubi, N., Vasselon, C., Archimbaud, E., Magaud, J., & Guyotat, D. (1993) · Blood · doi:10.1182/blood.v81.11.3091.3091 · Cited by 784
Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer
Pitti, R. M., Marsters, S. A., Lawrence, D. A., Roy, M., Kischkel, F. C., Dowd, P., Huang, A., Donahue, C. J., Sherwood, S. W., Baldwin, D. T., et al. (1998) · Nature · doi:10.1038/25387 · Cited by 783
Müller, M., Strand, S., Hug, H., Heinemann, E. M., Walczak, H., Hofmann, W. J., Stremmel, W., Krammer, P. H., & Galle, P. R. (1997) · Journal of Clinical Investigation · doi:10.1172/jci119174 · Cited by 748
Self-citationFulda, S., Wick, W., Weller, M., & Debatin, K.-M. (2002) · Nature Medicine · doi:10.1038/nm735 · Cited by 741
Self-citationIf not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells
Roninson, I. B., Broude, E. V., & Chang, B.-D. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0213 · Cited by 725
Defying death after DNA damage
Rich, T., Allen, R. L., & Wyllie, A. H. (2000) · Nature · doi:10.1038/35037717 · Cited by 724
Kasibhatla, S., Brunner, T., Genestier, L., Echeverri, F., Mahboubi, A., & Green, D. R. (1998) · Molecular Cell · doi:10.1016/s1097-2765(00)80054-4 · Cited by 721
Requirement for Caspase-2 in Stress-Induced Apoptosis Before Mitochondrial Permeabilization
Lassus, P., Opitz-Araya, X., & Lazebnik, Y. (2002) · Science · doi:10.1126/science.1074721 · Cited by 719
Chaudhary, P. M., Eby, M., Jasmin, A., Bookwalter, A., Murray, J., & Hood, L. (1997) · Immunity · doi:10.1016/s1074-7613(00)80400-8 · Cited by 711
Mitochondrial Release of Caspase-2 and -9 during the Apoptotic Process
Susin, S. A., Lorenzo, H. K., Zamzami, N., Marzo, I., Brenner, C., Larochette, N., Prévost, M.-C., Alzari, P. M., & Kroemer, G. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.381 · Cited by 710
Differential hepatocyte toxicity of recombinant Apo2L/TRAIL versions
Lawrence, D., Shahrokh, Z., Marsters, S., Achilles, K., Shih, D., Mounho, B., Hillan, K., Totpal, K., DeForge, L., Schow, P., et al. (2001) · Nature Medicine · doi:10.1038/86397 · Cited by 702
TRAIL Receptors 1 (DR4) and 2 (DR5) Signal FADD-Dependent Apoptosis and Activate NF-κB
Schneider, P., Thome, M., Burns, K., Bodmer, J.-L., Hofmann, K., Kataoka, T., Holler, N., & Tschopp, J. (1997) · Immunity · doi:10.1016/s1074-7613(00)80401-x · Cited by 696
The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet
van Loo, G., Saelens, X., van Gurp, M., MacFarlane, M., Martin, S. J., & Vandenabeele, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401088 · Cited by 665
Cloning and Characterization of TRAIL-R3, a Novel Member of the Emerging TRAIL Receptor Family
Degli-Esposti, M. A., Smolak, P. J., Walczak, H., Waugh, J., Huang, C.-P., DuBose, R. F., Goodwin, R. G., & Smith, C. A. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.7.1165 · Cited by 629
The CD95 (APO-1/Fas) and the TRAIL (APO-2L) Apoptosis Systems
Walczak, H., & Krammer, P. H. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4840 · Cited by 628
Self-citationMarsden, V. S., O'Connor, L., O'Reilly, L. A., Silke, J., Metcalf, D., Ekert, P. G., Huang, D. C. S., Cecconi, F., Kuida, K., Tomaselli, K. J., et al. (2002) · Nature · doi:10.1038/nature01101 · Cited by 578
Identification and Molecular Cloning of Two Novel Receptors for the Cytotoxic Ligand TRAIL
MacFarlane, M., Ahmad, M., Srinivasula, S. M., Fernandes-Alnemri, T., Cohen, G. M., & Alnemri, E. S. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25417 · Cited by 557
Tumoricidal activity of a novel anti-human DR5 monoclonal antibody without hepatocyte cytotoxicity
Ichikawa, K., Liu, W., Zhao, L., Wang, Z., Liu, D., Ohtsuka, T., Zhang, H., Mountz, J. D., Koopman, W. J., Kimberly, R. P., et al. (2001) · Nature Medicine · doi:10.1038/91000 · Cited by 543
Chinnaiyan, A. M., Prasad, U., Shankar, S., Hamstra, D. A., Shanaiah, M., Chenevert, T. L., Ross, B. D., & Rehemtulla, A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.030545097 · Cited by 530
Diverse functions of JNK signaling and c-Jun in stress response and apoptosis
Leppä, S., & Bohmann, D. (1999) · Oncogene · doi:10.1038/sj.onc.1203173 · Cited by 522 · cited 1×
“Multiple stress-inducible molecules, for example, JNK, MAPK/ERK, NF-kB or ceramide have been implied in the regulation of apoptosis (Leppa and Bohmann, 1999; Davis, 2000; Karin et al., 2002).”
BackgroundInhibition of Fas death signals by FLIPs
Tschopp, J., Irmler, M., & Thome, M. (1998) · Current Opinion in Immunology · doi:10.1016/s0952-7915(98)80223-9 · Cited by 520
Samali, A. (1999) · The EMBO Journal · doi:10.1093/emboj/18.8.2040 · Cited by 519
The mitochondrial apoptosome: a killer unleashed by the cytochrome seas
Adrain, C., & Martin, S. J. (2001) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(01)01844-8 · Cited by 513
Anticancer therapy targeting the apoptotic pathway
Hu, W., & Kavanagh, J. J. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01277-4 · Cited by 510
Gascoyne, R. D., Adomat, S. A., Krajewski, S., Krajewska, M., Horsman, D. E., Tolcher, A. W., O'Reilly, S. E., Hoskins, P., Coldman, A. J., Reed, J. C., et al. (1997) · Blood · doi:10.1182/blood.v90.1.244 · Cited by 509
BCL-2 antisense therapy in patients with non-Hodgkin lymphoma
Webb, A., Cunningham, D., Cotter, F., Clarke, P., Di Stefano, F., Ross, P., Corbo, M., & Dziewanowska, Z. (1997) · The Lancet · doi:10.1016/s0140-6736(96)11103-x · Cited by 489
Serial killers: ordering caspase activation events in apoptosis
Slee, E., Adrain, C., & Martin, S. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400601 · Cited by 473
Immune escape of tumors: apoptosis resistance and tumor counterattack
Igney, F. H., & Krammer, P. H. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.6.907 · Cited by 468
Self-citationWaters, J. S., Webb, A., Cunningham, D., Clarke, P. A., Raynaud, F., di Stefano, F., & Cotter, F. E. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.9.1812 · Cited by 454
Hermine, O., Haioun, C., Lepage, E., d'Agay, M., Briere, J., Lavignac, C., Fillet, G., Salles, G., Marolleau, J., Diebold, J., et al. (1996) · Blood · doi:10.1182/blood.v87.1.265.265 · Cited by 452
Kang, S.-M., Schneider, D. B., Lin, Z., Hanahan, D., Dichek, D. A., Stock, P. G., & Baekkeskov, S. (1997) · Nature Medicine · doi:10.1038/nm0797-738 · Cited by 450
Prevention of Islet Allograft Rejection with Engineered Myoblasts Expressing FasL in Mice
Lau, H. T., Yu, M., Fontana, A., & Stoeckert, C. J. (1996) · Science · doi:10.1126/science.273.5271.109 · Cited by 445
Prevention of Constitutive TNF Receptor 1 Signaling by Silencer of Death Domains
Jiang, Y., Woronicz, J. D., Liu, W., & Goeddel, D. V. (1999) · Science · doi:10.1126/science.283.5401.543 · Cited by 417
Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
Adida, C., Berrebi, D., Peuchmaur, M., Reyes-Mugica, M., & Altieri, D. C. (1998) · The Lancet · doi:10.1016/s0140-6736(05)70294-4 · Cited by 415
The molecular basis and potential role of survivin in cancer diagnosis and therapy
Altieri, D. C. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(01)02243-2 · Cited by 412
Fulda, S., Küfer, M. U., Meyer, E., van Valen, F., Dockhorn-Dworniczak, B., & Debatin, K.-M. (2001) · Oncogene · doi:10.1038/sj.onc.1204750 · Cited by 404
Self-citationChemotherapy: targeting the mitochondrial cell death pathway
Debatin, K.-M., Poncet, D., & Kroemer, G. (2002) · Oncogene · doi:10.1038/sj.onc.1206039 · Cited by 396
Self-citationThe Role of Caspases in Development, Immunity, and Apoptotic Signal Transduction
Los, M., Wesselborg, S., & Schulze-Osthoff, K. (1999) · Immunity · doi:10.1016/s1074-7613(00)80062-x · Cited by 391
Colomo, L., López-Guillermo, A., Perales, M., Rives, S., Martı́nez, A., Bosch, F., Colomer, D., Falini, B., Montserrat, E., & Campo, E. (2003) · Blood · doi:10.1182/blood-2002-04-1286 · Cited by 391
Allison, J., Georgiou, H. M., Strasser, A., & Vaux, D. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.8.3943 · Cited by 366
Parker, J. E., Mufti, G. J., Rasool, F., Mijovic, A., Devereux, S., & Pagliuca, A. (2000) · Blood · doi:10.1182/blood.v96.12.3932 · Cited by 363
Takimoto, R., & El-Deiry, W. S. (2000) · Oncogene · doi:10.1038/sj.onc.1203489 · Cited by 360 · cited 1×
“The molecular mechanisms that account for this synergistic interaction may include transcriptional upregulation of the agonistic TRAIL receptors TRAILR1 and TRAIL-R2, which occurred in a p53-dependent or -independent manner (Takimoto and El-Deiry, 2000; Meng and El-Deiry, 2001).”
BackgroundDel Poeta, G., Venditti, A., Del Principe, M. I., Maurillo, L., Buccisano, F., Tamburini, A., Cox, M. C., Franchi, A., Bruno, A., Mazzone, C., et al. (2003) · Blood · doi:10.1182/blood-2002-06-1714 · Cited by 340
Grønbæk, K., Straten, P. T., Ralfkiaer, E., Ahrenkiel, V., Andersen, M. K., Hansen, N. E., Zeuthen, J., Hou-Jensen, K., & Guldberg, P. (1998) · Blood · doi:10.1182/blood.v92.9.3018 · Cited by 336
Protein Complexes Activate Distinct Caspase Cascades in Death Receptor and Stress-Induced Apoptosis
Bratton, S. B., MacFarlane, M., Cain, K., & Cohen, G. M. (2000) · Experimental Cell Research · doi:10.1006/excr.2000.4835 · Cited by 332
Bennett, M. W., O’Connell, J., O’Sullivan, G. C., Brady, C., Roche, D., Collins, J. K., & Shanahan, F. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.11.5669 · Cited by 326
A CASP-8 Mutation Recognized by Cytolytic T Lymphocytes on a Human Head and Neck Carcinoma
Mandruzzato, S., Brasseur, F., Andry, G., Boon, T., & Bruggen, P. V. D. (1997) · The Journal of Experimental Medicine · doi:10.1084/jem.186.5.785 · Cited by 321
Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs
Micheau, O., Solary, E., Hammann, A., & Dimanche-Boitrel, M.-T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7987 · Cited by 320
Hill, M., MacLennan, K., Cunningham, D., Vaughan Hudson, B., Burke, M., Clarke, P., Di Stefano, F., Anderson, L., Vaughan Hudson, G., Mason, D., et al. (1996) · Blood · doi:10.1182/blood.v88.3.1046.1046 · Cited by 314
Regulation of death receptor expression and TRAIL/Apo2L-induced apoptosis by NF-κB
Ravi, R., Bedi, G. C., Engstrom, L. W., Zeng, Q., Mookerjee, B., Gélinas, C., Fuchs, E. J., & Bedi, A. (2001) · Nature Cell Biology · doi:10.1038/35070096 · Cited by 312
Human brain-cell death induced by tumour-necrosis-factor-related apoptosis-inducing ligand (TRAIL)
Nitsch, R., Bechmann, I., Deisz, R. A., Haas, D., Lehmann, T. N., Wendling, U., & Zipp, F. (2000) · The Lancet · doi:10.1016/s0140-6736(00)02659-3 · Cited by 300
Ultraviolet Radiation-induced Apoptosis Is Mediated by Activation of CD-95 (Fas/APO-1)
Rehemtulla, A., Hamilton, C. A., Chinnaiyan, A. M., & Dixit, V. M. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.41.25783 · Cited by 295
Wesselborg, S., Engels, I. H., Rossmann, E., Los, M., & Schulze-Osthoff, K. (1999) · Blood · doi:10.1182/blood.v93.9.3053 · Cited by 292
Cell surface Death Receptor signaling in normal and cancer cells
Özören, N., & El-Deiry, W. S. (2003) · Seminars in Cancer Biology · doi:10.1016/s1044-579x(02)00131-1 · Cited by 289
The role of Fas ligand in immune privilege
Green, D. R., & Ferguson, T. A. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35103104 · Cited by 284
Altered methylation patterns in cancer cell genomes: Cause or consequence?
Baylin, S., & Bestor, T. H. (2002) · Cancer Cell · doi:10.1016/s1535-6108(02)00061-2 · Cited by 280
Activation of CD95 (APO-1/Fas) signaling by ceramide mediates cancer therapy-induced apoptosis
Herr, I. (1997) · The EMBO Journal · doi:10.1093/emboj/16.20.6200 · Cited by 278
Ehrhardt, H., Fulda, S., Schmid, I., Hiscott, J., Debatin, K.-M., & Jeremias, I. (2003) · Oncogene · doi:10.1038/sj.onc.1206520 · Cited by 272
Self-citationEischen, C. M., Kottke, T. J., Martins, L. M., Basi, G. S., Tung, J. S., Earnshaw, W. C., Leibson, P. J., & Kaufmann, S. H. (1997) · Blood · doi:10.1182/blood.v90.3.935 · Cited by 269
Alterations in the apoptotic machinery and their potential role in anticancer drug resistance
Kaufmann, S. H., & Vaux, D. L. (2003) · Oncogene · doi:10.1038/sj.onc.1206945 · Cited by 265
Arnt, C. R., Chiorean, M. V., Heldebrant, M. P., Gores, G. J., & Kaufmann, S. H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m207578200 · Cited by 263
IFNγ sensitizes for apoptosis by upregulating caspase-8 expression through the Stat1 pathway
Fulda, S., & Debatin, K.-M. (2002) · Oncogene · doi:10.1038/sj.onc.1205255 · Cited by 260
Self-citationHolcik, M., & Korneluk, R. G. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35080103 · Cited by 251
Noncaspase proteases in apoptosis
Johnson, D. (2000) · Leukemia · doi:10.1038/sj.leu.2401879 · Cited by 250
Cheok, M. H., Yang, W., Pui, C.-H., Downing, J. R., Cheng, C., Naeve, C. W., Relling, M. V., & Evans, W. E. (2003) · Nature Genetics · doi:10.1038/ng1151 · Cited by 249
Tang, D., Lahti, J. M., & Kidd, V. J. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.13.9303 · Cited by 248
Gene transfer of Fas ligand induces tumor regression in vivo
Arai, H., Gordon, D., Nabel, E. G., & Nabel, G. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13862 · Cited by 248
Cross-Talk in Cell Death Signaling
Roy, S., & Nicholson, D. W. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.192.8.f21 · Cited by 248
Cowling, V, & Downward, J. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401065 · Cited by 248
Kataoka, T., Schröter, M., Hahne, M., Schneider, P., Irmler, M., Thome, M., Froelich, C. J., & Tschopp, J. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.8.3936 · Cited by 243
Apoptosis without caspases: an inefficient molecular guillotine?
Borner, C., & Monney, L. (1999) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400525 · Cited by 242
Ionov, Y., Yamamoto, H., Krajewski, S., Reed, J. C., & Perucho, M. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.190210897 · Cited by 242
Bargou, R. C., Daniel, P. T., Mapara, M. Y., Bommert, K., Wagener, C., Kallinich, B., Royer, H. D., & Dörken, B. (1995) · International Journal of Cancer · doi:10.1002/ijc.2910600622 · Cited by 237
Inhibition of Nuclear Factor κB Activation Attenuates Apoptosis Resistance in Lymphoid Cells
Jeremias, I., Kupatt, C., Baumann, B., Herr, I., Wirth, T., & Debatin, K. M. (1998) · Blood · doi:10.1182/blood.v91.12.4624 · Cited by 230
Self-citationFulda, S., Meyer, E., Friesen, C., Susin, S. A., Kroemer, G., & Debatin, K.-M. (2001) · Oncogene · doi:10.1038/sj.onc.1204141 · Cited by 223
Self-citationMarcucci, G., Byrd, J. C., Dai, G., Klisovic, M. I., Kourlas, P. J., Young, D. C., Cataland, S. R., Fisher, D. B., Lucas, D., Chan, K. K., et al. (2003) · Blood · doi:10.1182/blood-2002-06-1899 · Cited by 222
Ziegler, A., Luedke, G. H., Stahel, R. A., Zangemeister-Wittke, U., Fabbro, D., & Altmann, K.-H. (1997) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/89.14.1027 · Cited by 215
Clinical relevance of BCL-2 overexpression in childhood acute lymphoblastic leukemia
Coustan-Smith, E., Kitanaka, A., Pui, C., McNinch, L., Evans, W., Raimondi, S., Behm, F., Arico, M., & Campana, D. (1996) · Blood · doi:10.1182/blood.v87.3.1140.bloodjournal8731140 · Cited by 208
Deficient activation of the CD95 (APO-1/Fas) system in drug-resistant cells
Friesen, C., Fulda, S., & Debatin, K.-M. (1997) · Leukemia · doi:10.1038/sj.leu.2400827 · Cited by 207
Self-citationIsotype-Dependent Inhibition of Tumor Growth In Vivo by Monoclonal Antibodies to Death Receptor 4
Chuntharapai, A., Dodge, K., Grimmer, K., Schroeder, K., Marsters, S. A., Koeppen, H., Ashkenazi, A., & Kim, K. J. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.166.8.4891 · Cited by 202
Lowe, S. W. (1995) · Current Opinion in ONCOLOGY · doi:10.1097/00001622-199511000-00013 · Cited by 194
YAMAMOTO, H., PEREZPITEIRA, J., YOSHIDA, T., TERADA, M., ITOH, F., IMAI, K., & PERUCHO, M. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70499-3 · Cited by 187
Harper, N., Farrow, S. N., Kaptein, A., Cohen, G. M., & MacFarlane, M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m105693200 · Cited by 187
Prognostic significance of apoptosis regulators in breast cancer.
Krajewski, S., Krajewska, M., Turner, B. C., Pratt, C., Howard, B., Zapata, J. M., Frenkel, V, Robertson, S., Ionov, Y., Yamamoto, H., et al. (1999) · Endocrine-related cancer · doi:10.1677/erc.0.0060029 · Cited by 186
p53 and bcl-2 expression in high-grade B-cell lymphomas: correlation with survival time
Piris, M., Pezzella, F., Martinez-Montero, J., Orradre, J., Villuendas, R., Sanchez-Beato, M., Cuena, R., Cruz, M., Martinez, B., Garrido, M., et al. (1994) · British Journal of Cancer · doi:10.1038/bjc.1994.61 · Cited by 185
Human Ovarian Cancer and Cisplatin Resistance: Possible Role of Inhibitor of Apoptosis Proteins1
Li, J., Feng, Q., Kim, J.-M., Schneiderman, D., Liston, P., Li, M., Vanderhyden, B., Faught, W., Fung, M. F. K., Senterman, M., et al. (2001) · Endocrinology · doi:10.1210/endo.142.1.7897 · Cited by 185
Prokop, A., Wieder, T., Sturm, I., Eβmann, F., Seeger, K., Wuchter, C., Ludwig, W.-D., Henze, G., Dörken, B., & Daniel, P. (2000) · Leukemia · doi:10.1038/sj.leu.2401866 · Cited by 183
Expression and prognostic significance of survivin in de novo acute myeloid leukaemia
Adida, C., Récher, C., Raffoux, E., Daniel, M., Taksin, A.-L., Rousselot, P. H., Sigaux, F., Degos, L., Altieri, D. C., & Dombret, H. (2000) · British Journal of Haematology · doi:10.1046/j.1365-2141.2000.02328.x · Cited by 182
Chemosensitivity of solid tumor cells in vitro is related to activation of the CD95 system
Fulda, S., Łoś, M., Friesen, C., & Debatin, K. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980330)76:1<105::aid-ijc17>3.0.co;2-b · Cited by 182
Self-citationFas/Fas Ligand Interaction Contributes to UV-Induced Apoptosis in Human Keratinocytes
Leverkus, M., Yaar, M., & Gilchrest, B. A. (1997) · Experimental Cell Research · doi:10.1006/excr.1997.3514 · Cited by 177
Radiation and stress-induced apoptosis: A role for Fas/Fas ligand interactions
Reap, E. A., Roof, K., Maynor, K., Borrero, M., Booker, J., & Cohen, P. L. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.11.5750 · Cited by 173
Sturm, I., Köhne, C.-H., Wolff, G., Petrowsky, H., Hillebrand, T., Hauptmann, S., Lorenz, M., Dörken, B., & Daniel, P. T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.5.1364 · Cited by 173
Effects of Survivin Antagonists on Growth of Established Tumors and B7-1 Immunogene Therapy
Kanwar, J. R., Shen, W.-P., Kanwar, R. K., Berg, R. W., & Krissansen, G. W. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.20.1541 · Cited by 172
Life and death decisions: regulation of apoptosis by proteolysis of signaling molecules
Utz, P. J., & Anderson, P. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400696 · Cited by 170
Apoptosis: implications of basic research for clinical oncology
Tamm, I., Schriever, F., & Dörken, B. (2001) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00193-5 · Cited by 166
Wajant, H., Pfizenmaier, K., & Scheurich, P. (2002) · APOPTOSIS · doi:10.1023/a:1020039225764 · Cited by 163
Somatic mutations of TRAIL-receptor 1 and TRAIL-receptor 2 genes in non-Hodgkin's lymphoma
Lee, S. H., Shin, M. S., Kim, H. S., Lee, H. K., Park, W. S., Kim, S. Y., Lee, J. H., Han, S. Y., Park, J. Y., Oh, R. R., et al. (2001) · Oncogene · doi:10.1038/sj.onc.1204103 · Cited by 162
Guo, F., Nimmanapalli, R., Paranawithana, S., Wittman, S., Griffin, D., Bali, P., O'Bryan, E., Fumero, C., Wang, H. G., & Bhalla, K. (2002) · Blood · doi:10.1182/blood.v99.9.3419 · Cited by 162
Apolinario, R. M., van der Valk, P., de Jong, J. S., Deville, W., van Ark-Otte, J., Dingemans, A. M., van Mourik, J. C., Postmus, P. E., Pinedo, H. M., & Giaccone, G. (1997) · Journal of Clinical Oncology · doi:10.1200/jco.1997.15.6.2456 · Cited by 161
The relationship between bcl‐2 expression and response to chemotherapy in acute leukaemia
Maung, Z. T., MacLean, F. R., Reid, M. M., Pearson, A. D. J., Proctor, S. J., Hamilton, P. J., & Hall, A. G. (1994) · British Journal of Haematology · doi:10.1111/j.1365-2141.1994.tb04984.x · Cited by 161
Thymineless death in colon carcinoma cells is mediated via Fas signaling
Houghton, J. A., Harwood, F. G., & Tillman, D. M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.15.8144 · Cited by 158
Survivin and apoptosis control
Altieri, D. C. (2003) · Advances in cancer research · doi:10.1016/s0065-230x(03)88303-3 · Cited by 157
Caspase 2 and Caspase 3 Protein Levels as Predictors of Survival in Acute Myelogenous Leukemia
Estrov, Z. E., Thall, P. F., Talpaz, M., Estey, E. H., Kantarjian, H. M., Andreeff, M., Harris, D., Van, Q., Walterscheid, M., & Kornblau, S. M. (1998) · Blood · doi:10.1182/blood.v92.9.3090 · Cited by 156
Rau, B., Sturm, I., Lage, H., Berger, S. M., Schneider, U., Hauptmann, S., Wust, P., Riess, H. B., Schlag, P. M., Dörken, B., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.07.077 · Cited by 155
Rudin, C. M., Otterson, G. A., Mauer, A. M., Villalona-Calero, M. A., Tomek, R. M., Prange, B., George, C., Szeto, L. L., & Vokes, E. E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf124 · Cited by 155
Tepper, C. G., & Seldin, M. F. (1999) · Blood · doi:10.1182/blood.v94.5.1727 · Cited by 154
Eichhorst, S. T., Müller, M., Li‐Weber, M., Schulze‐Bergkamen, H., Angel, P. E., & Krammer, P. H. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.20.7826-7837.2000 · Cited by 154
Self-citationMeng, R. D., & El‐Deiry, W. S. (2001) · Experimental Cell Research · doi:10.1006/excr.2000.5073 · Cited by 150
Insights into cancer therapeutic design based on p53 and TRAIL receptor signaling
El‐Deiry, W. S. (2001) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400943 · Cited by 150
Lauria, F., Raspadori, D., Rondelli, D., Ventura, M. A., Fiacchini, M., Visani, G., Forconi, F., & Tura, S. (1997) · Leukemia · doi:10.1038/sj.leu.2400854 · Cited by 149
López‐Guillermo, A., Cabanillas, F., McDonnell, T. J., McLaughlin, P. J., Smith, T., Pugh, W. C., Hagemeister, F. B., Rodriguez, M. A., Romaguera, J. E., Younes, A., et al. (1999) · Blood · doi:10.1182/blood.v93.9.3081.409a43_3081_3087 · Cited by 148
Solary, É., Droin, N. M., Bettaïeb, A., Corcos, L., Dimanche‐Boitrel, M., & Garrido, C. (2000) · Leukemia · doi:10.1038/sj.leu.2401902 · Cited by 148
Beltinger, C., Fulda, S., Kammertoens, T., Meyer, E., Uckert, W., & Debatin, K.-M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.15.8699 · Cited by 143
Self-citationInactivating mutations of CASP10 gene in non-Hodgkin lymphomas
Shin, M. S., Kim, H. S., Kang, C. S., Park, W. S., Kim, S. Y., Lee, S. N., Lee, J., Park, J. Y., Jang, J. J., Kim, C. W., et al. (2002) · Blood · doi:10.1182/blood.v99.11.4094 · Cited by 142
Villunger, A., Egle, A., Marschitz, I., Kos, M., Böck, G., Ludwig, H., Geley, S., Kofler, R., & Greil, R. (1997) · Blood · doi:10.1182/blood.v90.1.12 · Cited by 140
Meng, R. D., McDonald, E. R., Sheikh, M. S., Fornace, A. J., & El‐Deiry, W. S. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0025 · Cited by 136
Fulda, S., Strauß, G., Meyer, É., & Debatin, K. (2000) · Blood · doi:10.1182/blood.v95.1.301 · Cited by 134
Self-citationFulda, S., Scaffidi, C., Pietsch, T., Krammer, P. H., Peter, M. E., & Debatin, K. (1998) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400419 · Cited by 131
Self-citationSensitization of resistant lymphoma cells to irradiation-induced apoptosis by the death ligand TRAIL
Belka, C., Schmid, B., Marini, P., Durand, E., Rudner, J., Faltin, H., BAMBERG, M., Schulze‐Osthoff, K., & Budach, W. (2001) · Oncogene · doi:10.1038/sj.onc.1204318 · Cited by 129
Bcl-2 Family Proteins: Strategies for Overcoming Chemoresistance in Cancer
Reed, J. C. (1997) · Advances in pharmacology · doi:10.1016/s1054-3589(08)61070-4 · Cited by 124
ten Berge, R. L., Meijer, C. J. L. M., Dukers, D. F., Kummer, J. A., Bladergroen, B. A., Vos, W., Hack, C. E., Ossenkoppele, G. J., & Oudejans, J. J. (2002) · Blood · doi:10.1182/blood.v99.12.4540 · Cited by 121
Two CD95 tumor classes with different sensitivities to antitumor drugs
Algeciras-Schimnich, A., Pietras, E. M., Barnhart, B. C., Legembre, P., Vijayan, S., Holbeck, S. L., & Peter, M. E. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2034995100 · Cited by 118
Inhibition of NF-κB Activity Enhances TRAIL Mediated Apoptosis in Breast Cancer Cell Lines
Keane, M., Rubinstein, Y., Cuello, M. A., Ettenberg, S. A., Banerjee, P., Nau, M. M., & Lipkowitz, S. (2000) · Breast Cancer Research and Treatment · doi:10.1023/a:1006458407515 · Cited by 112
Lee, S. H., Shin, M. S., Kim, H. S., Park, W. S., Kim, S. Y., Jang, J., Lee, H. K., Park, J. Y., Oh, R. R., Han, S. Y., et al. (2000) · Journal of Investigative Dermatology · doi:10.1046/j.1523-1747.2000.00819.x · Cited by 111
Tumor B Cells From Non-Hodgkin's Lymphoma Are Resistant to CD95 (Fas/Apo-1)–Mediated Apoptosis
Plumas, J., Jacob, M., Chaperot, L., Molens, J., Sotto, J., & Bensa, J. (1998) · Blood · doi:10.1182/blood.v91.8.2875.2875_2875_2885 · Cited by 110
Sturm, I., Petrowsky, H., Volz, R., Lorenz, M., Radetzki, S., Hillebrand, T., Wolff, G., Hauptmann, S., Dörken, B., & Daniel, P. T. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.8.2272 · Cited by 108
Hogarth, L., & Hall, A. G. (1999) · Blood · doi:10.1182/blood.v93.8.2671 · Cited by 103
Activation of apoptosis pathways in peripheral blood lymphocytes by in vivo chemotherapy
Stahnke, K., Fulda, S., Friesen, C., Strauß, G., & Debatin, K. (2001) · Blood · doi:10.1182/blood.v98.10.3066 · Cited by 103
Self-citationRassidakis, G. Z., Medeiros, L. J., Vassilakopoulos, T. P., Viviani, S., Bonfante, V., Nadali, G., Herling, M., Angelopoulou, M. K., Giardini, R., Chilosi, M., et al. (2002) · Blood · doi:10.1182/blood.v100.12.3935 · Cited by 103
Röhn, T. A., Wagenknecht, B., Roth, W., Naumann, U., Gulbins, E., Krammer, P. H., Walczak, H., & Weller, M. (2001) · Oncogene · doi:10.1038/sj.onc.1204534 · Cited by 102
Self-citationThe role of Fas and FasL as mediators of anticancer chemotherapy
Poulaki, V., Mitsiades, C. S., & Mitsiades, N. (2001) · Drug Resistance Updates · doi:10.1054/drup.2001.0210 · Cited by 100
XIAP Regulates DNA Damage-induced Apoptosis Downstream of Caspase-9 Cleavage
Datta, R., Oki, E., Endo, K., Biedermann, V., Ren, J., & Kufe, D. W. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m910231199 · Cited by 96
Inactivating mutations of the caspase-10 gene in gastric cancer
Park, W. S., Lee, J., Shin, M. S., Park, J. Y., Kim, H. S., Lee, J. H., Kim, Y. S., Lee, S. H., Xiao, W., Park, C. H., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205394 · Cited by 93
Defective death receptor signaling as a cause of tumor immune escape
French, L. E., & Tschopp, J. (2002) · Seminars in Cancer Biology · doi:10.1006/scbi.2001.0405 · Cited by 93
Olsson, A., Diaz, T., Aguilar‐Santelises, M., Österborg, A., Celsing, F., Jondal, M., & Osorio, L. (2001) · Leukemia · doi:10.1038/sj.leu.2402287 · Cited by 89
Hyer, M. L., Voelkel‐Johnson, C., Rubinchik, S., Dong, J.-Y., & Norris, J. S. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0139 · Cited by 89
Wuchter, C., Karawajew, L., Ruppert, V., Büchner, T., Schoch, C., Haferlach, T., Ratei, R., Dörken, B., & Ludwig, W.-D. (1999) · Leukemia · doi:10.1038/sj.leu.2401605 · Cited by 85
Olie, R. A., Hafner, C., Küttel, R., Sigrist, B., Stahel, R. A., Zangemeister‐Wittke, U., Willers, J., Dummer, R., & Hall, J. (2002) · Journal of Investigative Dermatology · doi:10.1046/j.0022-202x.2001.01677.x · Cited by 83
Friesen, C., Fulda, S., & Debatin, K. (1999) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400512 · Cited by 83
Self-citationThe origin of CD95-gene mutations in B-cell lymphoma
Müschen, M., Rajewsky, K., Krönke, M., & Küppers, R. (2002) · Trends in Immunology · doi:10.1016/s1471-4906(01)02115-9 · Cited by 82
Expression and prognostic significance of Bcl‐2 family proteins in myelodysplastic syndromes
Boudard, D., Vasselon, C., Berthéas, M., Jaubert, J., Mounier, C., Reynaud, J., Viallet, A., Chautard, S., Guyotat, D., & Campos, L. (2002) · American Journal of Hematology · doi:10.1002/ajh.10108 · Cited by 80
Alterations of Fas-pathway genes associated with nodal metastasis innon-small cell lung cancer
Shin, M. S., Kim, H. S., Lee, S. H., Lee, J. W., Song, Y. H., Kim, Y. S., Park, W. S., Kim, S. Y., Lee, S. N., Park, J. Y., et al. (2002) · Oncogene · doi:10.1038/sj.onc.1205527 · Cited by 79
Immune Response and Myoblasts That Express Fas Ligand
Kang, S., Hofmann, A., Le, D., Springer, M. L., Stock, P. G., & Blau, H. M. (1997) · Science · doi:10.1126/science.278.5341.1322 · Cited by 78
French, L. E., & Tschopp, J. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.190.7.891 · Cited by 78
木下, 博., Yoshikawa, H., Shiiki, K., Hamada, Y., Nakajima, Y., & Tasaka, K. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20001215)88:6<986::aid-ijc23>3.0.co;2-b · Cited by 77
Cited by
Cancer drug resistance: an evolving paradigm
Holohan, C., Van Schaeybroeck, S., Longley, D. B., & Johnston, P. G. (2013) · Nature Reviews Cancer · doi:10.1038/nrc3599 · Cited by 4,681
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
Cancer despite immunosurveillance: immunoselection and immunosubversion
Zitvogel, L., Tesniere, A., & Kroemer, G. (2006) · Nature reviews. Immunology · doi:10.1038/nri1936 · Cited by 1,324
The many roles of FAS receptor signaling in the immune system
Strasser, A., Jost, P. J., & Nagata, S. (2009) · Immunity · doi:10.1016/j.immuni.2009.01.001 · Cited by 968
“Some time ago, it was proposed that FAS-induced apoptosis occurs not only when FASL-expressing killer cells engage FAS+ target cells, but also when cells are treated with certain chemotherapeutic drugs or g-radiation (Debatin and Krammer, 2004).”
Li-Weber, M. (2009) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2008.09.005 · Cited by 896
Metadata
- Authors
- Debatin, K.-M., & Krammer, P. H.
- Venue
- Oncogene
- Published
- 2004-04-12
- Volume
- 23
- Issue
- 16
- Pages
- 2950-2966
- ISSN
- 0950-9232 (ISSN-L)
- 1476-5594
- OpenAlex
- W2074152898
- Cited by
- 505
- References
- 227
- FWCI
- 14.65
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.